Own blood used in experimental eye treatment to halt blinding disease
NCT ID NCT07428798
Summary
This small study tested whether injections of a patient's own concentrated blood plasma (platelet-rich plasma or PRP) could slow the progression of advanced dry age-related macular degeneration (AMD), a leading cause of vision loss. In 14 participants, one eye received three PRP injections over 10 weeks while the other eye was left untreated for comparison. Researchers measured whether the treatment slowed the growth of damaged areas in the retina and helped preserve vision and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Marmara University School of Medicine, Department of Ophthalmology
Istanbul, Istanbul, 34899, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.